Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2018-05-30
Original SEC Filing: Click here

---

Webplus: BSPM/20180530/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, May 30, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on May 23, 2018 it received a notification letter from Nasdaq Listing Qualifications (“Nasdaq”) advising the Company that, since it had not

---

---

Webplus: BSPM/20180530/8-K/1/000.htm SEC Original: biostar8k053018.htm
______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): May 23, 2018 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last

---

Company Info:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2018-05-30CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046